Oren Smaletz

Sao Paulo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Comparative perioperative and early oncologic outcomes of robot-assisted versus open retroperitoneal lymph node dissection in testicular germ cell tumors-experience from a tertiary Latin American referral center.

Comparative perioperative and early oncologic outcomes of robot-assisted versus open retroperitoneal lymph node dissection in testicular germ cell tumors-experience from a tertiary Latin American referral center.

Journal: Surgical oncology

Published: January 20, 2026

Androgen Receptor Pathway Inhibitor Therapy for Advanced Prostate Cancer: Secondary Analysis of a Randomized Clinical Trial.

Androgen Receptor Pathway Inhibitor Therapy for Advanced Prostate Cancer: Secondary Analysis of a Randomized Clinical Trial.

Journal: JAMA network open

Published: January 13, 2025

New Molecular Targets in Prostate Cancer-The Emerging Role of ACP1 and Low Molecular Weight Protein Tyrosine Phosphatase.

New Molecular Targets in Prostate Cancer-The Emerging Role of ACP1 and Low Molecular Weight Protein Tyrosine Phosphatase.

Journal: JCO precision oncology

Published: November 20, 2024

Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update.

Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update.

Journal: Journal of cancer research and clinical oncology

Published: December 27, 2023

Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer.

Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer.

Journal: European urology oncology

Published: August 31, 2023

Multicenter Database of Patients with Germ-Cell Tumors: A Latin American Cooperative Oncology Group Registry (LACOG 0515).

Multicenter Database of Patients with Germ-Cell Tumors: A Latin American Cooperative Oncology Group Registry (LACOG 0515).

Journal: Clinical genitourinary cancer

Published: September 06, 2022

"Non-metastatic, Castration-resistant Prostate Cancer: Diagnostic and Treatment Recommendations by an Expert Panel from Brazil".

"Non-metastatic, Castration-resistant Prostate Cancer: Diagnostic and Treatment Recommendations by an Expert Panel from Brazil".

Journal: Clinical genitourinary cancer

Published: May 09, 2022

Phase II trial of humanized anti-Lewis Y monoclonal antibody for advanced hormone receptor-positive breast cancer that progressed following endocrine therapy.

Phase II trial of humanized anti-Lewis Y monoclonal antibody for advanced hormone receptor-positive breast cancer that progressed following endocrine therapy.

Journal: Clinics (Sao Paulo, Brazil)

Published: May 18, 2021

A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415).

A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415).

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 15, 2021

Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer.

Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer.

Journal: JCO precision oncology

Published: February 18, 2021

Phase II consolidation trial with anti-Lewis-Y monoclonal antibody (hu3S193) in platinum-sensitive ovarian cancer after a second remission.

Phase II consolidation trial with anti-Lewis-Y monoclonal antibody (hu3S193) in platinum-sensitive ovarian cancer after a second remission.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: November 10, 2020

Neutropenia Prevention in the Treatment of Post-docetaxel Metastatic, Castration-resistant Prostate Cancer With Cabazitaxel and Prednisone: A Multicenter, Open-label, Single-arm Phase IV Study.

Neutropenia Prevention in the Treatment of Post-docetaxel Metastatic, Castration-resistant Prostate Cancer With Cabazitaxel and Prednisone: A Multicenter, Open-label, Single-arm Phase IV Study.

Journal: Clinical genitourinary cancer

Published: July 07, 2020

Showing 1-12 of 26

Last Updated: 09/26/2026